wild tiger casino
Matvei Michkov did it again in overtime. The prized rookie winger scored his third OT winner, lifting the Flyers to a 3-2 decision Saturday night over the Blues at Enterprise Center in St. Louis. Philadelphia news 24/7: Watch NBC10 free wherever you are Travis Konecny made an outstanding play to spring the 19-year-old for a breakaway goal. Last season, the Flyers won only four games in overtime. Owen Tippett and Tyson Foerster also scored for the Flyers (12-10-3), who are 8-2-2 in their last 12 games. They've gone to OT in eight of those 12 games. The Flyers are also 11-5-2 since Oct. 26. In that span, only two teams have more points than their 24: the Hurricanes and Capitals, each with 25. John Tortorella's club picked up its first win when playing on the second night of a back-to-back set. The Flyers were 0-3-0 in such situations and had been outscored 16-9 before beating St. Louis. They were able to build off their 3-1 Black Friday win over the Rangers . Complete coverage of the Philadelphia Flyers and their rivals in the NHL from NBC Sports Philadelphia. In this busy stretch of three games through four days, the Flyers won all three and allowed just five goals. The Flyers swept the two-game regular-season series from the Blues (11-12-2). They beat St. Louis, 2-1, on Halloween . This time, they handed Jim Montgomery his first loss as the Blues' head coach. Montgomery, now 2-0-1 with St. Louis, was fired by the Bruins last week. • Michkov's former development coach called him a "spotlight player" and we're seeing why. The youngster from Russia just seems to have a flair for the dramatic. And the Flyers have needed that type of talent. Michkov also had an assist on Tippett's marker. He leads all rookies in goals (nine), points (19), power play goals (four), power play assists (five) and overtime goals (three). "When the game's on the line, when something needs to happen, some players sort of like to hide in those situations," Daniel Bochner said in July 2023 . "Where he sort of likes to be the guy that says, 'Hey, give me the puck, I'm going to do something here.'" • Aleksei Kolosov was huge for the Flyers, converting 25 saves on 27 shots. He couldn't have done much more on Jake Neighbours' game-tying goal with 20 seconds left in regulation. The Blues had a 6-on-4 as they emptied their net on a power play. Kolosov made back-to-back saves right before Neighbours scored. St. Louis cracked Kolosov with 8:49 minutes remaining to draw even at 1-1. Prior to that, Kolosov twice upheld the Flyers' 1-0 lead with excellent saves on breakaways. The first came on Jordan Kyrou in the final three minutes of the first period and the second on Mathieu Joseph in the opening five minutes of the second period. Foerster regained the Flyers their lead 51 seconds after Dylan Holloway tied things up. Over his last three starts, the 22-year-old Kolosov has gone 3-0-0 with 69 saves on 75 shots. Samuel Ersson, recovering from a lower-body injury, missed a ninth straight game. Could he be nearing a return? More on that here . Blues netminder Jordan Binnington was spectacular, stopping 28 of the Flyers' 31 shots. He absolutely robbed Sean Couturier with just under a minute left in the second period on a sprawling glove save. A post shared by St. Louis Blues (@stlouisblues) • How about Konecny? Since Oct. 23, he's among the top five scorers in the NHL with 27 points (11 goals, 16 assists) over 19 games. More: Konecny has quietly been 'terrific' while also helping Michkov • Jamie Drysdale was out for a 10th straight game with an upper-body injury. After sitting the last four games as a healthy scratch, Egor Zamula drew back into the lineup for Helge Grans. He finished as a minus-1 in 14:39 minutes. • The Flyers go the next four days without a game before hosting the Panthers on Thursday (7 p.m. ET/NBCSP). Subscribe anywhere you get your podcasts: Apple Podcasts | Youtube Music | Spotify | Stitcher | Simplecast | RSS | Watch on YouTubeThe AP Top 25 men’s college basketball poll is back every week throughout the season! Get the poll delivered straight to your inbox with AP Top 25 Poll Alerts. Sign up here . NATCHITOCHES, La. (AP) — Addison Patterson’s 33 points led Northwestern State over Southern University at New Orleans 89-79 on Friday. Patterson had 10 rebounds for the Demons (6-5). JT Warren scored 11 points, shooting 5 for 11, including 1 for 3 from beyond the arc. Landyn Jumawan went 2 of 7 from the field (2 for 5 from 3-point range) to finish with eight points. Tyon Thompson led the way for the Knights with 21 points, six assists and three steals. Jamal Gibson added 18 points, seven rebounds and three steals for Southern University at New Orleans. Tony White also recorded 10 points and three steals. NEXT UP Northwestern State visits Texas in its next matchup on December 29. ___ The Associated Press created this story using technology provided by Data Skrive and data from Sportradar .Intech Investment Management LLC bought a new stake in shares of Kadant Inc. ( NYSE:KAI – Free Report ) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 2,384 shares of the industrial products company’s stock, valued at approximately $806,000. Other hedge funds have also recently made changes to their positions in the company. Janus Henderson Group PLC lifted its position in Kadant by 15.1% in the 1st quarter. Janus Henderson Group PLC now owns 22,324 shares of the industrial products company’s stock valued at $7,321,000 after acquiring an additional 2,923 shares in the last quarter. Hsbc Holdings PLC boosted its position in shares of Kadant by 133.3% during the second quarter. Hsbc Holdings PLC now owns 3,066 shares of the industrial products company’s stock valued at $902,000 after buying an additional 1,752 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its holdings in Kadant by 16.1% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 793 shares of the industrial products company’s stock worth $268,000 after buying an additional 110 shares in the last quarter. Raymond James & Associates raised its position in Kadant by 6.5% in the 2nd quarter. Raymond James & Associates now owns 84,117 shares of the industrial products company’s stock worth $24,712,000 after buying an additional 5,167 shares during the last quarter. Finally, Sanctuary Advisors LLC bought a new position in Kadant during the 2nd quarter valued at about $615,000. 96.13% of the stock is owned by institutional investors. Analyst Upgrades and Downgrades Separately, Barrington Research restated an “outperform” rating and set a $360.00 price objective on shares of Kadant in a research report on Wednesday, October 30th. Kadant Stock Up 2.3 % KAI stock opened at $412.79 on Friday. The business’s 50-day moving average is $354.00 and its two-hundred day moving average is $321.01. The company has a market cap of $4.85 billion, a price-to-earnings ratio of 42.25 and a beta of 1.21. Kadant Inc. has a fifty-two week low of $249.51 and a fifty-two week high of $429.95. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.46 and a current ratio of 2.29. Kadant ( NYSE:KAI – Get Free Report ) last posted its quarterly earnings data on Tuesday, October 29th. The industrial products company reported $2.84 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.43 by $0.41. Kadant had a net margin of 11.12% and a return on equity of 15.10%. The company had revenue of $271.61 million for the quarter, compared to the consensus estimate of $266.38 million. During the same quarter last year, the firm posted $2.69 earnings per share. The firm’s revenue was up 11.2% compared to the same quarter last year. As a group, analysts forecast that Kadant Inc. will post 10.11 earnings per share for the current year. Kadant Dividend Announcement The business also recently declared a quarterly dividend, which will be paid on Thursday, February 6th. Shareholders of record on Thursday, January 9th will be issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.31%. The ex-dividend date is Thursday, January 9th. Kadant’s dividend payout ratio is presently 13.10%. Insiders Place Their Bets In related news, Director Thomas C. Leonard sold 152 shares of the company’s stock in a transaction on Tuesday, November 19th. The shares were sold at an average price of $398.21, for a total value of $60,527.92. Following the completion of the transaction, the director now owns 4,250 shares of the company’s stock, valued at approximately $1,692,392.50. This represents a 3.45 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link . Also, VP Fredrik H. Westerhout sold 600 shares of the stock in a transaction on Monday, November 18th. The stock was sold at an average price of $397.25, for a total value of $238,350.00. Following the completion of the sale, the vice president now owns 1,437 shares of the company’s stock, valued at $570,848.25. The trade was a 29.46 % decrease in their position. The disclosure for this sale can be found here . Insiders sold a total of 3,052 shares of company stock worth $1,091,455 over the last quarter. 1.40% of the stock is currently owned by corporate insiders. Kadant Company Profile ( Free Report ) Kadant Inc supplies technologies and engineered systems worldwide. It operates in three segments: Flow Control, Industrial Processing, and Material Handling. The Flow Control segment develops, manufactures, and markets fluid-handling systems and equipment, such as rotary joints, syphons, turbulator bars, expansion joints, and engineered steam and condensate systems; and doctoring, cleaning, and filtration systems and related consumables consisting of doctor systems and holders, doctor blades, cleaning shower and fabric-conditioning systems, forming systems and wear surfaces, and water-filtration systems. Further Reading Five stocks we like better than Kadant How to Calculate Retirement Income: MarketBeat’s Calculator The Latest 13F Filings Are In: See Where Big Money Is Flowing Should You Add These Warren Buffett Stocks to Your Portfolio? 3 Penny Stocks Ready to Break Out in 2025 10 Best Airline Stocks to Buy FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential Receive News & Ratings for Kadant Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kadant and related companies with MarketBeat.com's FREE daily email newsletter .
Patterson scores 33, Northwestern State takes down Southern University at New Orleans 89-79
Democrat divisions simmer on Hunter Biden pardon — as Joe prepares to depart political scene
NEW YORK (AP) — President-elect Donald Trump’s lawyers formally asked a judge Monday to throw out his hush money criminal , arguing continuing the case would present unconstitutional “disruptions to the institution of the Presidency.“ In a filing made public Tuesday, Trump’s lawyers told Manhattan Judge Juan M. Merchan that dismissal is warranted because of the extraordinary circumstances of his impending to the White House. “Wrongly continuing proceedings in this failed lawfare case disrupts President Trump’s transition efforts,” the attorneys continued, before citing the “overwhelming national mandate granted to him by the American people on November 5, 2024.” Trump’s lawyers also cited President Joe Biden’s recent of his son, Hunter Biden, who had been convicted of . “President Biden asserted that his son was ‘selectively, and unfairly, prosecuted,’ and ‘treated differently,’" Trump’s legal team wrote. The Manhattan district attorney, they claimed, had engaged in the type of political theater "that President Biden condemned.” Prosecutors will have until Dec. 9 to respond. They have said they will fight any efforts to dismiss the case but have indicated openness to delaying sentencing until after Trump’s second term ends in 2029. In their filing Monday, Trump's attorneys dismissed the idea of holding off sentencing until Trump is out of office as a “ridiculous suggestion.” Following Trump’s election victory last month, Merchan halted proceedings and indefinitely postponed his sentencing, previously scheduled for late November, to allow the defense and prosecution to weigh in on the future of the case. He also delayed a decision on Trump’s to dismiss the case on immunity grounds. Trump has been fighting for months to reverse the conviction, which involved efforts to conceal a $130,000 payment to porn actor Stormy Daniels, whose affair allegations threatened to disrupt his 2016 campaign. He has denied any wrongdoing. Trump takes office on Jan. 20. Merchan hasn’t set a timetable for a decision. The defense filing was signed by Trump lawyers Todd Blanche and Emil Bove, who represented Trump during the trial and have since been selected by the president-elect to fill senior roles at the Justice Department. A dismissal would erase Trump’s historic conviction, sparing him the cloud of a criminal record and possible prison sentence. Trump is the first former president to be convicted of a crime and the first convicted criminal to be elected to the office. Merchan could also decide to uphold the verdict and proceed to sentencing, delay the case until Trump leaves office, wait until a federal appeals court rules on Trump’s parallel effort to get the case moved out of state court or choose some other option. Trump was convicted in May on 34 counts of falsifying business records to conceal a to porn actor Stormy Daniels, just before the 2016 presidential election, to suppress her claim that they had sex a decade earlier. He says they did not and denies any wrongdoing. Prosecutors cast the payout as part of a Trump-driven effort to keep voters from hearing salacious stories about him. Trump’s then-lawyer Michael Cohen paid Daniels. Trump later reimbursed him, and Trump’s company logged the reimbursements as legal expenses — concealing what they really were, prosecutors alleged. Trump has pledged to appeal the verdict if the case is not dismissed. He and his lawyers said the payments to Cohen were properly categorized as legal expenses for legal work.
Eazeye Radiant TLCD Monitor Offers Several Advantages Over LCDWinthrop Rockefeller Foundation Celebrates 50 Years of Transformative Impact in Arkansas
Advisors Asset Management Inc. raised its holdings in shares of Crinetics Pharmaceuticals, Inc. ( NASDAQ:CRNX – Free Report ) by 56.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,806 shares of the company’s stock after buying an additional 1,008 shares during the period. Advisors Asset Management Inc.’s holdings in Crinetics Pharmaceuticals were worth $143,000 at the end of the most recent reporting period. A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Driehaus Capital Management LLC boosted its holdings in Crinetics Pharmaceuticals by 17.0% during the 2nd quarter. Driehaus Capital Management LLC now owns 6,112,173 shares of the company’s stock valued at $273,764,000 after acquiring an additional 885,876 shares during the period. Vanguard Group Inc. lifted its position in Crinetics Pharmaceuticals by 2.1% in the first quarter. Vanguard Group Inc. now owns 3,575,076 shares of the company’s stock valued at $167,349,000 after purchasing an additional 72,624 shares during the last quarter. Jennison Associates LLC boosted its stake in shares of Crinetics Pharmaceuticals by 0.5% during the third quarter. Jennison Associates LLC now owns 2,793,614 shares of the company’s stock valued at $142,754,000 after purchasing an additional 13,470 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A. grew its holdings in shares of Crinetics Pharmaceuticals by 0.6% in the second quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 546,234 shares of the company’s stock worth $24,466,000 after purchasing an additional 3,526 shares during the last quarter. Finally, Affinity Asset Advisors LLC grew its holdings in shares of Crinetics Pharmaceuticals by 9.6% in the second quarter. Affinity Asset Advisors LLC now owns 515,000 shares of the company’s stock worth $23,067,000 after purchasing an additional 45,000 shares during the last quarter. 98.51% of the stock is owned by institutional investors. Insider Transactions at Crinetics Pharmaceuticals In other news, COO Jeff E. Knight sold 501 shares of Crinetics Pharmaceuticals stock in a transaction that occurred on Friday, November 22nd. The shares were sold at an average price of $56.52, for a total transaction of $28,316.52. Following the completion of the transaction, the chief operating officer now directly owns 51,653 shares in the company, valued at approximately $2,919,427.56. This trade represents a 0.96 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website . Also, CFO Marc Wilson sold 25,000 shares of the company’s stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $51.11, for a total value of $1,277,750.00. Following the completion of the sale, the chief financial officer now owns 111,092 shares in the company, valued at $5,677,912.12. The trade was a 18.37 % decrease in their position. The disclosure for this sale can be found here . Insiders have sold 40,911 shares of company stock valued at $2,144,675 in the last three months. 6.00% of the stock is currently owned by company insiders. Crinetics Pharmaceuticals Stock Performance Crinetics Pharmaceuticals ( NASDAQ:CRNX – Get Free Report ) last issued its quarterly earnings results on Tuesday, November 12th. The company reported ($0.96) earnings per share for the quarter, missing the consensus estimate of ($0.91) by ($0.05). During the same period in the prior year, the firm earned ($1.01) earnings per share. On average, equities analysts forecast that Crinetics Pharmaceuticals, Inc. will post -3.75 EPS for the current fiscal year. Wall Street Analysts Forecast Growth Several brokerages have weighed in on CRNX. Cantor Fitzgerald reissued an “overweight” rating and set a $90.00 price target on shares of Crinetics Pharmaceuticals in a research report on Monday, September 16th. JMP Securities reiterated a “market outperform” rating and set a $80.00 target price on shares of Crinetics Pharmaceuticals in a report on Friday, September 27th. Oppenheimer restated an “outperform” rating and set a $73.00 price target (down previously from $74.00) on shares of Crinetics Pharmaceuticals in a report on Friday, August 9th. Citigroup upped their price target on Crinetics Pharmaceuticals from $70.00 to $74.00 and gave the company a “buy” rating in a research report on Thursday, November 14th. Finally, HC Wainwright lifted their price objective on Crinetics Pharmaceuticals from $69.00 to $81.00 and gave the stock a “buy” rating in a research report on Wednesday, November 13th. One research analyst has rated the stock with a hold rating and ten have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $70.18. Get Our Latest Stock Report on CRNX Crinetics Pharmaceuticals Company Profile ( Free Report ) Crinetics Pharmaceuticals, Inc, a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's lead product candidate is paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist, which is in Phase 3 trial for the treatment of acromegaly; and Phase 2 trial for treating carcinoid syndrome associated with neuroendocrine tumors. Featured Stories Five stocks we like better than Crinetics Pharmaceuticals 3 Fintech Stocks With Good 2021 Prospects The Latest 13F Filings Are In: See Where Big Money Is Flowing Which Wall Street Analysts are the Most Accurate? 3 Penny Stocks Ready to Break Out in 2025 Airline Stocks – Top Airline Stocks to Buy Now FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential Receive News & Ratings for Crinetics Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crinetics Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter .Proposed winter rate hikes ignite renewed debate over Connecticut’s high electricity costs
Published 22:10 IST, November 24th 2024 Former CJI Chandrachud said that retired judges must exercise caution while making any such decisions, which can have a bearing on the public. New Delhi: Former Chief Justice of India, DY Chandrachud, on Sunday said that society continues to view retired judges as integral members of the judiciary, adding that judges have to walk a tightrope as as they are not viewed in the bracket of common citizens by the public. Former CJI Chandrachud, whose two-year tenure ended on November 10, said that retired judges must exercise caution and consider whether their actions can affect the public. Is it Right to Enter Politics For Retired Judges? Here’s What Ex-CJI Chandrachud Said "Society continues to look at you as a judge even after retirement, therefore, things which are alright for other citizens to do would not be alright for judges to do even when they demit office,” Chandrachud said. "Primarily it is for every judge to take a call on whether a decision which he takes after retirement will have a bearing on people who assess the work which he did as a judge," he added. At his farewell ceremony organized by the SC Bar Association earlier this month, DY Chandrachud, who is known for his landmark judgments and eloquent speeches mixed with a poetic twist, was at his poetic best when he responded to his trolls by quoting Urdu poet Bashir Badr. Quoting the famous Urdu poet, the former CJI trolled the trollers in his unique style, saying, “Mukhalfat se meri shakhsiyat sanwarti hai, main dushmano ka bada ehtiraam karta hun (Opposition improves my personality, I respect my enemies a lot).” The house burst into laughter when he said, “I am probably the most trolled judge across the system." Justice Chandrachud, the 50th CJI, assumed office on November 9, 2022, following in the footsteps of his father, YV Chandrachud, who served as the longest-serving Chief Justice from 1978 to 1985. Justice Sanjiv Khanna was sworn in as the 51st Chief Justice of India on November 11 in a ceremony at Rashtrapati Bhavan. Get Current Updates on India News , Entertainment News along with Latest News and Top Headlines from India and around the world. 22:10 IST, November 24th 2024
Winnipeg Jets (18-6, in the Central Division) vs. Dallas Stars (14-8, in the Central Division) Dallas; Sunday, 4:30 p.m. EST BOTTOM LINE: The Dallas Stars host the Winnipeg Jets after Mason Marchment scored two goals in the Stars' 5-3 win over the Colorado Avalanche. Dallas has a 14-8 record overall and a 5-2-0 record in Central Division play. The Stars have a +17 scoring differential, with 76 total goals scored and 59 conceded. Winnipeg has an 18-6 record overall and a 7-1-0 record in Central Division play. The Jets have gone 10-1-0 in games they score at least one power-play goal. Sunday's game is the second time these teams square off this season. The Jets won the last matchup 4-1. Cole Perfetti scored two goals in the victory. TOP PERFORMERS: Marchment has nine goals and 14 assists for the Stars. Roope Hintz has five goals and one assist over the last 10 games. Kyle Connor has 13 goals and 16 assists for the Jets. Mark Scheifele has scored five goals with three assists over the past 10 games. LAST 10 GAMES: Stars: 6-4-0, averaging 3.9 goals, 6.6 assists, 3.3 penalties and 8.6 penalty minutes while giving up three goals per game. Jets: 5-5-0, averaging three goals, 4.7 assists, 4.2 penalties and 11.7 penalty minutes while giving up 2.7 goals per game. INJURIES: Stars: None listed. Jets: None listed. The Associated Press created this story using technology provided by Data Skrive and data from Sportradar .UN human rights watchdog opens investigation into Venezuela presidential election
Chuck Woolery, smooth-talking game show host of 'Love Connection' and 'Scrabble,' dies at 83With just six weeks remaining in the 2024 season, the Buffalo Bills are in a great position in the AFC playoff race. Sitting just one game behind the Kansas City Chiefs for a top seed and a first-round bye, the Bills have greater aspirations than simply making the postseason in 2024. (Mark Konezny-Imagn Images) Many did not expect the team to perform at the level they have this season. A massive reason for that was their decision to trade All-Pro receiver Stefon Diggs in the offseason after a strained 2023 season. However, the decision has certainly paid off for Buffalo, as quarterback Josh Allen is an MVP contender and the Bills are in a great position. In a recent article released by The Athletic's Mike Sando , an anonymous NFL coach praised the Bills for their handling of the situation. “The coach and GM (Brandon Beane) had the foresight to get rid of (Diggs) because they knew it was detrimental to the quarterback and the atmosphere,” the coach said. “All of [the] sudden, they are playing with Curtis Samuel and draft picks and just whatever, and the quarterback is playing good. And then they add Amari Cooper.” Related: Bills' Upcoming Opponent Provides Big QB Injury Update An anonymous league executive also told Sando that people doubting Buffalo in the offseason has benefitted them. “I don’t see how Buffalo melts down unless they have a ton of injuries,” said the executive. “I’m not sure what the catalyst has been, except that maybe they have been off everybody’s radar long enough... They are clearly operating better in those conditions than having the spotlight on them.” Related: What's Josh Allen's One 'Scary' Trait in Bills Super Bowl Push?
NoneDemocrat divisions simmer on Hunter Biden pardon — as Joe prepares to depart political sceneDallas plays Winnipeg after Marchment's 2-goal performance